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Left Ventricular Dimensions and Autonomic Balance During Head-Up 
Tilt Differ Between Patients With Isoproterenol-Dependent and 
Isoproterenol-Independent Neurally Mediated Syncope 
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Objectives. This study sought o elucidate differences in mech- 
anisms of neurally mediated syncope between patients with syn- 
cope induced by head-up tilt alone and those requiring isoproter- 
enol infusion to induce syncope during head-up tilt. 
Background. Some patients with neurally mediated syncope 
require isoproterenol to induce syncope during head-up tilt 
(isoproterenol dependent), and others do not (isoproterenol inde- 
pendent). Differences in mechanisms between these two groups 
have not been well elucidated. 
Methods. A 60* head-up tilt test was performed in 13 patients 
with isoproterenoMndependent syncope (Group I, mean [_+SD] 
age 28 -+ 12 years), 14 patients with isoproterenol-dependent 
syncope (Group II, mean age 34 _+ 14 years) and 20 control 
subjects without syncope (Group III, mean age 32 -+ 12 years). 
Left ventricular size and contractility were determined by echo- 
cardiography, and sympathovagal b lance was determined with 
power spectral analysis of heart rate variability using a maximal 
entropy method. 
Results. Group I patients had smaller left ventricular dimen- 
sions than Groups II and III during baseline tilt. During head.up 
tilt with isoproterenoi infusion (0.01 to 0.04/xg/kg body weight per 
min), left ventricular dimensions decreased tothe same extent in 
Groups II and III, but fractional shortening was greater in Group 
II than in Group III at the end of the tilt. The ratio of low (0.05 to 
0.15 Hz) to high frequency (0.15 to 1.0 Hz) component became 
greater in Group I than in Groups H and III during the last period 
of baseline tilt. However, the ratio was greater in Group II than in 
Group III during the last period of the tilt with isoproterenol. 
Conclusions. Patients with isoproterenoMndependent syncope 
had an exaggerated decrease in left ventricular size and sympa- 
thetic predominance preceding syncope during head-up tilt. In 
contrast, in patients with isoproterenol-dependent syncope, simi- 
lar changes in autonomic nervous balance were evident only 
during isoproterenol infusion in addition to head-up tilt. 
(J Am Coil Cardiol 1995;26:164-73) 
Syncope due to neurally mediated hypotension and bradycar- 
dia (i.e., vasovagal syncope) is believed to account for the 
mechanism of unexplained syncope, especially in patients 
without apparent structural cardiovascular disease (1,2). Re- 
cently, the head-up tilt test has been shown to be a useful tool 
for the diagnosis of unexplained syncope during the tilt test 
(1-9). Several observations (2,3,5,6,9) suggest that the hypo- 
tension and bradycardia induced by head-up tilt are essentially 
equivalent to the spontaneous episodes of neurally mediated 
syncope. However, the exact mechanism of hypotension and 
bradycardia induced by head-up tilt is not yet well understood, 
and why the vasovagal reflex occurs during head-up tilt only in 
susceptible patients i still obscure. Some patients with neurally 
mediated syncope require isoproterenol infusion to induce 
syncope (isoproterenol dependent) (1-3,5), whereas others do 
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not (isoproterenol independent) (3,10,11). Differences in the 
mechanisms of syncope between these two patient groups are 
still not well understood. Therefore, the present study sought 
to determine changes in left ventricular size and contractility 
and in sympathovagal balance in these two groups of patients 
with neurally mediated syncope and in a group of control 
subjects. 
Methods  
Patient selection. Patients who had been referred for diag- 
nosis of unexplained syncope were included in the study if they 
met the following criteria: 1) at least one syncopal episode, the 
cause of which remained uncertain despite a careful history, 
comprehensive physical examination, neurologic evaluation, 
12-lead electrocardiogram (ECG), 24-h ambulatory Holter 
monitoring and echocardiography; 2) no history of drug use 
known to cause orthostatic hypotension; 3) technically optimal 
echocardiographic images; 4) normal left ventricular wall 
motion evaluated by echocardiography; 5) no evidence of 
©1995 by the American College of Cardiolc~gy 0735-1097/95/$9.50 
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Table 1. Clinical Characteristics of Study Subjects 
Group [ Group II Group II1 
(n 13) (n - 14) (n = 20) 
Age (yr) 28 +_ 12 34 ± 14 32 _+ 12 
Gender (M/F) 11/2 10/4 11/9 
Syncopal episodes 15 + 111' 5 _+ 9 
Duration of symptoms (mo) 106 + 77+ 22 ± 44 
Associated cardiac disease 
VPC 3 3 3 
2nd-degree AV block 2 2 4 
PAF, PSVT 2 3 
MVP 2 1 
HT I 3 
Head-up tilt test 
Duration (rain) 9.6 + 4,0 8.4 ± 4.2 
IP dose (ng/kg per rain) 19 = 7 21 + 8 
Response type 
Vasodepressor 4 5 
Mixed 9 9 
*p < 0.05, "~p < 0.01 versus Group II. Data presented are mean value + SD 
or number of patients. AV = atrioventricular: F female; Group I = positive 
response during baseline head-up tilt; Group II = positive response only during 
isoproterenol infusion in addition to head-up tilt; Group III = control subjects; 
HT = hypertension; IP = isoproterenol; M - male; MVP = mitral valve 
prolapse; PAF = paroxysmal trial fibrillation; PSVT = paroxysmal supraven- 
tricular tachycardia; VPC - ventricular premature contraction. 
diabetes mellitus or neuropathy; 6) absence of frequent 
(>-5 beats/15 rain) atrial or ventricular premature beats and 
atrioventricular (AV) conduction block during the study pro- 
tocol (Table 1). 
Of 35 consecutive patients with unexplained syncope, 27 
met these criteria (21 men, 6 women; mean [+SD] age 31 _+ 13 
years, range 14 to 60). Eight patients were excluded from the 
study because of suboptimal quality of echocardiographic 
images in four, frequent atrial premature beats in two and 
Wenckebach AV block during the study protocol in two. The 
27 patients were classified into two groups: 13 with a positive 
response during baseline tilt alone (Group I) and 14 with a 
positive response only with the addition of intravenous isopro- 
terenol infusion (Group II). The day after the first head-up tilt 
test, the tilt test was repeated in8 of 13 patients in Group I and 
7 of 14 patients in Group II. The control group (Group III) 
included 20 subjects with no syncopal episodes and normal 
cardiac structure and function by conventional echocardio- 
graphic criteria with technically optimal images (11 men, 9 
women; mean age 32 _+ 12 years, range 13 to 67) (Table 1). 
Associated cardiovascular bnormalities for Group III patients 
are presented in Table 1. 
Head-up tilt test. Written informed consent was obtained 
from each subject. Head-up tilt test was performed in the 
fasting state (---4 h) after withdrawal of all cardioactive medi- 
cations at least 5 half-lives before the study. After 30-rain rest 
in the supine position, each subject was tilted to a 60 ° up- 
right position for 15 rain, with a footboard used for weight 
bearing (5,10-13). Blood pressure was determined by a cuff 
sphygmomanometer before and every l min after initiation of 
the tilt test. Mean blood pressure was calculated by adding one 
third of the pulse pressure to the diastolic pressure. If the 
results of the baseline head-up tilt test were negative (see 
later), the patient was returned to the supine position, and 
isoproterenol was infused intravenously at a rate of 0.01 to 
0.04 /xg/kg body weight per min in Groups II and III. The 
infusion rate was gradually increased until a 20% increase in 
heart rate was achieved, as in the previous tudy by Sra et al. 
(14). The head-up tilt was then repeated. A response was 
considered positive if significant arterial hypotension (decrease 
in mean blood pressure ->20 mm Hg) in association with 
syncope or presyncope was encountered. 
Electrocardiographic lead II was monitored throughout the 
study and recorded on a magnetic frequency modulation tape 
for later analysis. 
Eehoeardiographie evaluation. Two-dimensional targeted 
echocardiograms of the left ventricular cavity were recorded 
using a 3.75-MHz transducer (Toshiba SSH-140A). Two- 
dimensional echocardiography can provide reliable estimates 
of left ventricular volume using the short-axis Simpson rule or 
area-length method (15). However, during the head-up tilt, 
multiple cross-sectional areas between the apex and base of the 
left ventricular cavity could not be determined sufficiently, and 
optimal echocardiographic images of the apical view were 
difficult o obtain. Therefore, left ventricular dimensions from 
the parasternal long-axis view were used to estimate changes in 
left ventricular volume because left ventricular wall motion 
abnormalities were not present, and global left ventricular 
function appeared normal in the study groups. Two- 
dimensional echocardiograrns were recorded, along with a 
phonocardiogram in the supine position, within 1 rain after the 
initiation of head-up tilt and every 1 or 2 rain thereafter until 
the end of head-up tilt or the onset of a positive response. Left 
ventricular end-diastolic and end-systolic dimensions were 
determined using M-mode echocardiography at the peak of 
the R wave of the QRS complex and at the initial component 
of the second heart sound, respectively. Ventricular dimen- 
sions were determined independently b  two observers without 
knowledge of the result of the tilt test. Mean values of two 
observers were determined torepresent each subject. Percent 
left ventricular fractional shortening was calculated as follows: 
Fractional shortening (%) = [(End-diastolic dimension -
End-systolic dimension)/End-diastolic d mension] × 100. 
Heart rate spectral analysis. Assessment of heart rate 
variability provides a simple noninvasive means for quantita- 
tive analysis of cardiac sympathovagal tone (16-18). Heart rate 
variability was determined in the supine position and during 
the last 200 beats until I rain before the end of tilt in 10 Group 
I patients (mean age 30 +_ 15 years), 11 Group II patients 
(mean age 31 + 13 years) and 14 Group III subjects (mean age 
30 + 14 years). Off-line analysis was performed on a micro- 
computer (NEC PC-9801 RX). The ECG recordings were 
played back from the frequency modulation tape and input 
into the R wave detection differentiator to convert he R wave 
to the R wave trigger pulse. Then, RR intervals were measured 
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Table 2, Blood Pressure and Heart Rate During Head-Up Tilt Alone and Head-Up Tilt With Isoproterenol Infusion (mean _+ SD) 
Baseline HUT HUT With Isoproterenol 
I or 2 vain 1 or 2 vain 
Bcfore Beforc 
Supine 1 min Afl.cr End of End of Supine I min After End of End of 
Position Start of HUT HUT HUT Position Start of HUT HUT HUT 
BP (ram Hg) 
Group I 75 ± 6 72 + 7 58 -+ lll*t 45 ~ 12"t 
Group I1 82 _* 12 84 + 13 83 : 13 83 ± 12 83 + 10 83 _+ 10 70 ± 16~:§ 54_+ I1+$ 
Group III 80 ~ 15 78 * 15 77 = 12 79 + 13 76 ± 13 78 ± 11 79 ± 14 79 ± 13 
HR (heats/vain) 
Group 1 58 +~ 5 81 + 12' 83 -+ 20* 71 : 23 
Group II 66 = 81' s l / -  1~,* 85 + 15' 86 + 15t 1(16 = 20 112 + 19 109 + 20 94 + 24§ 
Group III 66 -~ 12i I 79 - l(~* 83 +_ 16" 85 -+ 20t 1(18 ± 22 115 _+ 23 128 _+ 24*+ 129 ± 27"+ 
*p < 0.001, Sp < 0.05 versus supine position, tp < 0.001, §p < 0.05 versus I vain. lip < 0.05 versus Group I. BP = blood pressure; HR - heart rate; HUT 
head-up tilt. 
by counting the number of 40-/.ts clocks between each consec- 
utive pulse and sampled at 2 Hz after the spline interpolation. 
All ECG recordings were reviewed on the computer display by 
two cardiologists, and a time series of 200 consecutive RR 
intervals comprising only normal sinus rhythms and in a 
stationary state were selected. Spectral indexes of heart rate 
variability were computed by a maximal entropy method using 
the Burg algorithm on 200 consecutive RR intervals. The 
direct current component was excluded from the power spec- 
tra. Power spectra were quantified by measuring the area in 
two frequency bandwidths: low frequency component (0.05 to 
0.15 Hz), a measure of sympathetic tone mediated by the 
parasympathetic nervous ystem, and high frequency compo- 
nent (0.15 to 1.0 Hz) reflecting parasympathetic activity. The 
ratio of low frequency to high frequency component was 
derived as a measure of sympathovagal balance (12,16-21). 
Statistical analysis. Results are presented as mean value _+ 
SD. The nonparametric Mann-Whitney U test was used for 
statistical comparison between two groups. Analysis of vari- 
ance was used to determine differences among the three 
groups. Analysis of variance for repeated measures was used 
for intragroup comparisons of hemodynamic, echocardio- 
graphic and heart rate spectral changes. Multiple comparisons 
were made using the Scheffe test; p < 0.05 was considered 
significant. 
Resu l ts  
Clinical characteristics. Pertinent data of the subjects are 
summarized in Table 1. There was no significant difference in 
age among the three groups. Group 1 patients had had more 
frequent episodes of syncope and had had a longer histo~ of 
syncope than Group II patients. Baseline left ventricular size 
and wall motion evaluated by echocardiography were within 
normal ranges. The duration of the control tilt in Group I did 
not differ from that with isoproterenol infusion in Group II. 
The maximal isoproterenol dosage did not differ between 
Groups II and III (Table 1). 
Cardiovascular responses. Two distinct response patterns 
of heart rate and blood pressure characterized asvasodepres- 
sor and mixed response (6,22) were identified. In Group I, four 
patients had a vasodepressor response inwhich symptoms were 
associated with hypotension alone, and another nine had a 
mixed response in which symptoms were associated with both 
hypotension and bradycardia. In Group II, five patients had a 
vasodepressor response, and another nine had a mixed re- 
sponse. Eight Group I patients and seven Group II patients 
repeated the head-up tilt test on the second day and had the 
same response as that on the first day. This result indicates that 
the response to the head-up tilt was reproducible in these 
patients. The data obtained on the first day were used for the 
following analyses: Changes in mean blood pressure and heart 
rate during the head-up tilt are shown in Table 2. Baseline 
mean blood pressure did not differ among the three groups. 
There was no significant change in mean blood pressure during 
the baseline tilt in both Groups II and III. However, it 
decreased significantly at 1 to 2 rain before and at the end of 
the baseline tilt when syncopal or presyncopal symptoms 
developed in Group I patients. Baseline heart rate was signif- 
icantly lower in Group I than in Groups II and III. During the 
baseline tilt, heart rate increased significantly from the baseline 
value in the three groups. At the end of the baseline tilt, heart 
rate tended to decrease in Group l, but the difference did not 
reach the significance level, possibly because of the vasode- 
pressor esponse without bradycardia that occurred in four 
patients. 
During the tilt with isoproterenol infusion, mean blood 
pressure decreased significantly 1 to 2 rain before and at the 
end of the tilt in Group II. However, it did not change 
significantly in Group III. Heart rate decreased significantly at 
the end of the tilt with isoproterenol infusion in Group II, but 
it increased significantly in Group III. 
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Figure 1. Top, Representative tracings of left ventric- 
ular M-mode echocardiogram from a 29-year old man 
in Group I during supine rest (left), at I min before the 
end of head-up tilt (HUT) (middle) and at the end of 
head-up tilt (right). At 1 rain before the end of 
head-up tilt, end-diastolic (EDD) and end-systolic 
dimensions (ESD) decreased from 48 to 35 mm and 
from 34 to 26 mm, respectively. At the end of 8-min 
tilt, end-diastolic and end-systolic dimensions de- 
creased further (32 and 22 mm, respectively), and 
blood pressure (BP) and heart rate (HR) decreased 
when the patient had presyncopal symptoms. Frac- 
tional shortening (FS) remained fairly stable through- 
out the study protocol. Bottom, Representative trac- 
ings of left ventricular M-mode echocardiogram from 
a 15-year old boy in Group II during supine rest (left), 
at the end of head-up tilt (HUT) (middle) and at the 
end of head-up tilt with isoproterenol infusion 
(HUT+IP) (right). At the end of head-up tilt, end- 
diastolic and end-systolic dimensions decreased to a 
smaller extent (from 50 to 44 and from 38 to 34 mm, 
respectively) than in the patient in Group I (top), and 
fractional shortening did not change. At the end of 
6-min head-up tilt with isoproterenol infusion, end- 
diastolic and end-systolic dimensions decreased (39 
and 23 mm, respectively), and fractional shortening 
increased (36%) when compared with the values at the 
end of control head-up tilt. Blood pressure and heart 
rate decreased when the patient had a presyncopal 
symptom. 
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Changes in echocardiographic variables. Representative 
examples of echocardiographic changes during the tilt are 
shown in Figure 1, and echocardiographic variables are sum- 
marized in Figures 2 to 4. Baseline nd-diastolic dimension was 
significantly greater in Group I than in Group III (49 _+ 3 vs. 
43 _+ 5 ram, p < 0.01) but did not differ between Group II 
(46 _+ 4 ram) and Group 1 or Group Ill. Baseline end-systolic 
dimension was not different among the study groups (Group I, 
32 _+ 3 ram; Group II, 31 _+ 6 ram; Group III, 30 : 5 mm). 
After starting the baseline tilt, end-diastolic and end-systolic 
dimensions decreased in all three groups but became smaller 
in Group I than in Groups II and III throughout the baseline 
tilt (Fig. 2 and 3, top). Fractional shortening did not change 
significantly in the three groups (Fig. 4, top). 
During the supine position with isoproterenol infusion, 
end-diastolic dimension decreased to 90 _+ 9% and 91 _+ 9% of 
the baseline value in Groups II and III, respectively. During 
the tilt with isoproterenol infusion, end-diastolic dimension 
decreased to the same extent in both groups and to the same 
level as in Group I during the baseline tilt (Fig. 1 and 2). 
End-systolic dimension also decreased to 80 _+ 13% and 76 _+ 
11% of the baseline value during the supine position with 
isoproterenol infusion in Groups II and III, respectively. 
End-systolic dimension also decreased to the same extent in 
both Groups II and III (Fig. 1 and 3). The percent decrease in 
end-systolic dimension was greater than that in end-diastolic 
dimension at the last 1 or 2 rain of the tilt, both in Group II 
(35 _+ 8% vs. 25 _+ 7%, p < 0.0005) and Group III (33 _+ 8% 
vs. 26 = 10%, p < 0.0005). Fractional shortening in the supine 
position therefore increased significantly after starting isopro- 
terenol infusion both in Group II (33 _+ 8% to 41 +_ 8%, p < 
0.001) and Group III (31 _+ 6% to 42 _+ 8%, p < 0.0001). 
Fractional shortening did not differ between these two groups 
throughout the tilt, except at the end of the tilt when it was 
greater in Group II than in Group II1 (Fig. 3, bottom). 
Heart rate variability. Representative changes in the 
power spectra of a Group I patient are shown in Figure 5. 
Among the three groups, the mean RR interval was not 
different during the supine position and during the last 200 
beats until 1 min before the end of the tilt. 
Changes in spectral components are summarized in Figures 
6 and 7. The low frequency power did not differ among the 
three groups during the supine period and throughout baseline 
tilt, although it tended to be greater in Group I than in the 
other groups (Fig. 6). The high frequency power tended to be 
greater in Groups I and II during the supine position, but the 
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Figure 2. Percent changes in end-diastolic dimension (%EDD) during 
control head-up tilt (Control HUT) (top) and head-up tilt with isoproter- 
enol infusion (HUT+IP) (bottom). In both panels, the baseline nd- 
diastolic dimension value during the supine position without isoproterenol 
infusion was expressed as 100%. Throughout the control head-up tilt, 
percent changes in end-diastolic dimension were lower in Group I 
(squares) than in Groups II (circles) and 1II (triangles). During tilt with 
isoproterenol infusion, percent changes in end-diastolic dimension in 
Groups II and III decreased tothe level of that in Group I during the 
control tilt but did not differ between Groups II and III during the tilt 
with isoproterenol infusion. SUPINE : during supine position; 
1 MIN = 1 rain after starting head-up tilt; BEFORE - 1 or 2 min before 
end of head-up tilt; END = end of head-up tilt. #p < 0.001 versus 
Group I. Results are mean value +_ SD. 
difference was not significant. During the last period of the 
head-up tilt, that is, the last 200 beats until 1 rain before the end 
of the tilt, the high frequency power decreased to the same level 
in the three groups, but the decrease was not statistically signifi- 
cant in Group II. The low frequency/high frequency ratio was not 
different among the three groups at the supine position. During 
the last period of the tilt, the low frequency/high frequency ratio 
increased significantly in all three groups, and became greater in 
Group I (5.1 + 2.4) than in Groups II and III (2.3 _+ 1.7 and 
2.2 _+ 1.1, respectively, p < 0.001) (Fig. 6). This finding indicates 
that sympathetic activity became predominant in Group I com- 
pared with the other groups during the head-up tilt. During the 
supine position with isoproterenol infusion, low and high fre- 
quency power tended to be smaller than the baseline values 
obtained before isoproterenol infusion both in Groups II and III 
and did not differ between the two groups (Fig. 7). The low 
frequency/high frequency ratio increased in both groups because 
high frequency power decreased more than the low frequency 
power after the start of isoproterenol infusion. During the last 
period of the head-up tilt with isoproterenol infusion, the low 
frequency/high frequency ratio became greater in Group II (3.2 + 
1.1) than in Group III (1.8 = 0.9, p < 0.01) (Fig. 7). The dosage 
of isoproterenol infusion was similar in the two groups (Table 1). 
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Figure 3. Changes in percent end-systolic dimension (%ESD) of the 
baseline value during control head-up tilt (HUT) (top) and head-up 
tilt with isoproterenol infusion (HUT+IP) (bottom). Throughout the 
control head-up tilt, changes in percent end-systolic dimension were 
smaller in Group I than in Groups II and III. During tilt with 
isoproterenol infusion in Groups II and III, changes in percent 
end-systolic dimension decreased to the level of that in Group I at the 
end of the control tilt but did not differ between Groups II and III 
during tilt with isoproterenol infusion. *p < 0.005, #p < 0.001 versus 
Group I. Format and other abbreviations a in Figure 2. 
Discuss ion  
The major findings of the present study are as follows: 1) 
Patients with isoproterenol-independent sy cope (Group I) 
had an exaggerated decrease in left ventricular size during 
head-up tilt alone. In these patients, the low frequency/high 
frequency ratio increased markedly, indicating alteration in 
sympathovagal balance leading to sympathetic predominance 
before the development of syncope. 2) In contrast, patients 
with isoproterenol-dependent sy cope (Group II) had sympa- 
thetic predominance during the tilt plus isoproterenol infusion 
compared with the control subjects (Group III), although left 
ventricular size decreased to the same extent in the other two 
groups. Contractility, expressed by fractional shortening, in- 
creased more in Group II than in Group III before the end of 
tilt with isoproterenol infusion. 
Changes in eehoeardiographic variables. In an earlier 
study by Shalev et al. (10), a progressive decrease in left 
ventricular size was demonstrated during head-up tilt alone in 
patients with isoproterenol-independent neurally mediated 
syncope, and a decrease in size became significantly greater in 
these patients than in patients with isoproterenol-dependent 
syncope and subjects with negative head-up tilt responses. 
However, left ventricular end-systolic size was smaller in 
patients with isoproterenol-dependent syncope than in tilt- 
negative subjects at the end of tilt. Fractional shortening 
therefore increased both in patients with isoproterenol- 
JACC Vol. 26. No. 1 MIZUMAKI ET AL. 169 
July 1995:164-73 MECHANISM OF NEURALLY MEDIATED SYNCOPE 
% FS 
4O 
35 
3O 
25 
2O 
- - - "o ' -  I 
Control HUT • 1, 
. . . .  ]~ ' "  I I I  
SUPINE IM IN  BEFORE END 
%FS 
55 
50-  
45-  
40-  
35-  
30 
• I !  
HUT + IP  .... 0 . . .  Ill 
11 
l" ............... T .............. 
SUPINE IM IN  BEFORE END 
Figure 4. Changes in fractional shortening (%FS) during control 
head-up tilt (HUT) (top) and head-up tilt with isoproterenol infusion 
(HUT+IP) (bottom). Control fractional shortening did not differ 
among the three groups and did not change significantly hroughout 
control tilt. During the supine position with isoproterenol infusion, 
fractional shortening increased significantly in Groups II and III. It did 
not differ between these two groups throughout the tilt with isopro- 
terenol except for the end of the tilt when it was significantly greater in
Group II than in Group IlI. *p < 0.05 versus Group III. Format and 
other abbreviations as in Figure 2. 
dependent and isoproterenol-independent syncope at the end 
of tilt (10). Their study suggested that left ventricular size 
decreased markedly during head-up tilt in patients with 
isoproterenol-independent n urally mediated syncope, a find- 
ing in accordance with our result. However, an initial decrease 
in left ventricular size at the beginning of tilt did not differ 
among the groups in the study of Shalev et al. (10). In contrast, 
in the present study, it decreased more at 1 rain after starting 
the tilt in patients with isoproterenol-independent sy cope 
than in other groups. 
Patients in whom syncope was induced uring head-up tilt 
had less variable venous tone and a larger increase in their calf 
blood volume during the tilt (23). The increase in calf blood 
volume was greater throughout the tilt in these patients than in 
those without symptoms (23). Other investigators (24) have 
also suggested that impaired early vasoconstricting responses 
to head-up tilt, leading to excessive venous pooling, might be a 
primary phenomenon responsible for increased susceptibility 
to tilt-induced vasovagal reactions. A decrease in the left 
ventricular size might therefore be greater in patients with 
tilt-induced syncope than in subjects without symptom, as 
shown in the present study. Vasoconstricting responses to tilt 
might be preserved both in patients with isoproterenol- 
dependent syncope and in control subjects because an exag- 
gerated ecrease in left ventricular size was not demonstrated 
during head-up tilt alone in these subjects in the present study. 
Normally, the decrease in venous return during head-up tilt 
leads to a diminution of baroreceptor inhibitory impulses, 
which enhances adrenergic sympathetic tone and reduces 
parasympathetic tone (4,25-28), as observed in the present 
study (Fig. 6). Consequently, augmented adrenergic tone in- 
creases myocardial contractile force and heart rate to compen- 
sate for the reduced stroke volume (29-31). As previously 
reported in animal studies (26,32) and during echocardio- 
graphic evaluation (10), increased contractility in the small eft 
ventricle might cause vasovagal reflex through stimulating left 
ventricular mechanoreceptors. However, fractional shortening, 
as an index of left ventricular contractility, did not increase in 
the present study because of variable changes of this variable in 
patients with isoproterenol-independent sy cope during 
head-up tilt, whereas an exaggerated decrease in left ventric- 
ular size was a consistent finding. Shalev et al. (10) reported 
that the increase in percent fractional shortening became 
significantly greater in patients with isoproterenol-dependent 
syncope than in control subjects during the tilt with isoproter- 
enol infusion. However, ventricular size was not described in 
their study (10). In the present study, a further decrease in left 
ventricular size, along with an increase in percent fractional 
shortening, was noted during the head-up tilt with isoprotere- 
nol infusion both in patients with isoproterenol-dependent 
syncope and in control subjects compared with the baseline tilt. 
However, left ventricular size and percent fractional shorten- 
ing did not differ between these two groups except for percent 
fractional shortening at the end of the tilt. These results 
suggest that a small difference in percent fractional shortening 
might be critical to induce syncope (Fig. 4), although yper- 
sensitivity of the mechanoreceptor might play some role in the 
initiation of vasovagal reflex during head-up tilt (33) because 
vasovagal reflex could not be induced in the control subjects 
with a similarly reduced left ventricular size. 
Changes in heart rate spectral characteristics during 
head-up tilt. Assessment of heart rate variability provides a 
simple noninvasive means for quantitative analysis of cardiac 
sympathovagal tone (16-18). By changing from supine to 
head-up tilt, low frequency power increased, whereas high 
frequency power decreased, resulting in an increase in the 
low frequency/high frequency ratio in normal subjects 
(16,17,19,20). In affected patients the increase in low frequency 
power and low frequency/high frequency ratio was greater 
before syncope than that in normal subjects (19,21). These 
findings indicate that the sympathovagal balance was altered, 
resulting in sympathetic predominance, and are in accordance 
with previous results (34) in which plasma catecholamine levels 
were elevated just before vasovagal symptoms. However, to 
our knowledge heart rate spectral characteristics have not 
been compared in patients with isoproterenol-dependent and 
isoproterenol-independent n urally mediated syncope. In the 
present study, the low frequency/high frequency ratio did not 
increase in patients with isoproterenol-dependent sy cope as 
much as in patients with isoproterenol-independent syncope 
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Figure 5. Representative changes inthe tachogram of 
RR interval (left) and power spectra of heart rate 
variability (right) from a 15-year old boy in Group I
during supine position (top) and head-up tilt (HUT) 
(middle) and at the end of head-up tilt with presyncope 
(END) (bottom). Right, Abscissa indicates frequency 
(Hz), and ordinate indicates power spectral density 
(PSD) (ms2). During head-up tilt, the high frequency 
(HF) component decreased, and the low frequency 
(LF) component (shown in black) became predomi- 
nant, resulting inan increase inthe low frequency/high 
frequency omponent ratio. At the end of head-up tilt, 
the high frequency omponent became predominant as 
the patient had a presyncopal symptom. It should be 
noted that scales of the ordinate are different. 
during the baseline tilt. Changes in the power spectral compo- 
nents of heart rate variability did not differ between patients 
with isoproterenol-dependent sy cope and control subjects 
during the baseline tilt. After administration of isoproterenol, 
the low frequency/high frequency ratio became greater before 
the end of the tilt in patients with isoproterenol-dependcnt 
syncope than in control subjects. 
Recently, Bloomfield et al. (35) indicated that head-up tilt 
at 60 ° decreased high frequency power more than an infusion 
of low dose isoproterenol (I /xg/min) in the supine position 
despite the finding that similar heart rates were attained (35). 
However, the effects of sympathomimetic drugs, including 
isoproterenol, on heart rate spectral components have not yet 
been fully understood, and the effect of tilt plus isoproterenol 
infusion on the autonomic nervous system balance has not 
been thoroughly analyzed. Contrary to expectations from 
previous results using beta-blockade (17), the administration 
of isoproterenol decreased not only high frequency power, but 
low frequency power during the supine position in the present 
study. However, as expected, isoproterenol increased baseline 
low frequency/high frequency ratio during the supine position 
and increased it more during tilt in the present study. The 
increase in low frequency/high frequency ratio during tilt was 
greater in patients with isoproterenol-dependent syncope than 
in control subjects. It was reported (36) that an increased 
beta-adrenergic sensitivity determined by graded isoproterenol 
infusion was associated with susceptibility o syncope in chil- 
dren and adolescents. Beta-adrenergic hypersensitivity, re- 
flected as an increase in percent fractional shortening and in 
the low frequency/high frequency ratio during head-up tilt with 
isoproterenol infusion, might be responsible for syncopal at- 
tack in our patients with isoproterenol-dependent syncope. 
Methodologic onsiderations. There is a potential limita- 
tion regarding the spectral analysis technique for evaluation 
of the response to physiologic perturbations such as postural 
tilt (i.e., nonstationary conditions might increase noises in 
the data). The consecutive 200 beats were analyzed to assess 
the changes in sympathovagal balance in the present study. 
This time period seemed too long to determine the dynamic, 
serial changes in autonomic nervous activities. Therefore, 
our interpretation would be hampered in this context. Some 
investigators (37) suggested that the autoregression method 
might be more sensitive to physiologic stress, such as 
head-up tilt. Care was taken in the present study to include 
heart rate data during supine and head-up tilt while subjects 
were asymptomatic and to exclude subjects with frequent 
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Figure 6. Power spectral components during the supine period and the 
last period of control head-up tilt (HUT) are summarized. Top, Low 
frequency (LF) component did not differ among the three groups 
during the supine period and during the last period of the control tilt, 
although it tended to be greater in Group 1 than in the other groups 
during tilt. Middle, High frequency (HF) component tended to be 
greater in Groups I and 11 during the supine period, but the difference 
was not significant. During head-up tilt, the high frequency component 
decreased to the same level in the three groups, but the decrease was 
not statistically significant in Group II. Bottom, The low frequency/ 
high frequency component ratio (LF/HF) was not different among the 
three groups during the supine period. During head-up tilt, the low 
frequency/high frequency component ratio increased significantly inall 
three groups because of a marked decrease in the high frequency 
component without appreciable changes in the low frequency compo- 
nent. The low frequency/high frequency component ratio in Group 1 
became greater than that in the other two groups. *p < 0.05, **p < 
0.005, ***p < 0.001 versus the supine position, #p < 0.001 versus 
Group I. 
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Figure 7. Power spectral components during the supine position 
and head-up tilt (HUT) after start of the isoproterenol (IP) 
infusion. During the supine position with isoproterenol infusion, 
low (LF) (top) and high frequency (HF) (middle) components 
tended to be smaller and the low frequency/high frequency compo- 
nent ratio (LF/HF) (bottom) greater as a result of a greater 
decrease in the high frequency than in the low frequency compo- 
nent in both Groups II and IIl compared with baseline values 
without isoproterenol shown in Figure 6. However, these variables 
did not differ between the two groups. During head-up tilt with 
isoproterenol infusion, the low frequency component became 
greater in Group I1 than in Group lit, and the high frequency 
component decreased significantly only in Group Ili. Consequently, 
the low frequency/high frequency component ratio became greater 
in Group II than in Group III. #p < 0.01 versus Group IlI. *p < 
0.05 versus the supine position and isoproterenol infusion. 
arrhythmias during the test. The very low frequency com- 
ponent (<0.05 Hz) was not analyzed in the present study 
because the significance of this component is still not clear. 
If the nonharmonic 1/f component (38) is completely elim- 
inated, this very low frequency component might reflect a 
function of some cardiovascular factors that include involve- 
ment of the renin-angiotensin system in heart rate changes 
(18). Although the groups were matched for age in the 
present study, it was not possible to match them for daily 
physical activities, which might have influenced the auto- 
nomic activities. Patients without optimal echocardiograms 
were excluded from the study, as mentioned in Methods. 
However, it seems unlikely that exclusion of these patients 
from the analysis affected the present results significantly 
because the number of patients excluded for this reason was 
small. The patients were classified into two groups: those 
who required isoproterenol infusion to induce syncope 
(isoproterenol dependent) and those who did not (isopro- 
terenol independent). This division was not complete be- 
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cause there were patients with positive tilt test results during 
infusion of nitroglycerin (39) or other substances (40,41). 
These patients would show a different response to echocardio- 
graphic measures and in heart rate variability during the head-up 
tilt test. Finally, the infusion rate of isoproterenol was determined 
according to a previous report (14), even though the impact of 
isoproterenol might differ at the level of the sinus node compared 
with that at the level of the vascular system (42). 
Conclusions. The present findings indicate that responses 
to head-up tilt differ between patients with isoproterenol- 
independent neurally mediated syncope and those with 
isoproterenol-dependent sy cope. The former have an exag- 
gerated decrease in left ventricular size and sympathetic 
predominance preceding syncope during head-up tilt alone. In 
contrast, he latter have a significant decrease in left ventricu- 
lar size and sympathetic predominance only during tilt with 
isoproterenol infusion. The different responses of fractional 
shortening and sympathovagal balance to isoproterenol infu- 
sion between patients with isoproterenol-dependent sy cope 
and control subjects uggest that different responses in periph- 
eral vasoconstriction rhypersensitivity of the mechanorecep- 
tor function, or both, could play some role in the genesis of 
neurally mediated syncope. 
We thank Dr. Katsumi Umcno tbr providing the software for the heart rate 
spectral analysis. 
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